Aerovate Therapeutics, Inc. (AVTE) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 2 Buy, 6 Hold.
The consensus price target is $13.00 (low: $2.00, high: $35.00), representing an upside of 385.1% from the current price $2.68.
AVTE Stock — 12-Month Price Forecast
$13.00
▲ +385.07% Upside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for Aerovate Therapeutics, Inc., the average price target is $13.00, with a high forecast of $35.00, and a low forecast of $2.00.
The average price target represents a +385.07% change from the last price of $2.68.
Highest Price Target
$35.00
Average Price Target
$13.00
Lowest Price Target
$2.00
AVTE Analyst Ratings
Hold
Based on 8 analysts giving stock ratings to Aerovate Therapeutics, Inc. in the past 3 months
